KIR2DL5A
Killer cell immunoglobulin-like receptor 2DL5A
Also known as: KI2LA_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for KIR2DL5A in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
375 residues, UniProt reviewed canonical sequence.
>Q8N109|KIR2DL5A
1 MSLMVISMAC VGFFLLQGAW THEGGQDKPL LSAWPSAVVP RGGHVTLLCR SRLGFTIFSL
61 YKEDGVPVPE LYNKIFWKSI LMGPVTPAHA GTYRCRGSHP RSPIEWSAPS NPLVIVVTGL
121 FGKPSLSAQP GPTVRTGENV TLSCSSRSSF DMYHLSREGR AHEPRLPAVP SVNGTFQADF
181 PLGPATHGGT YTCFGSLHDS PYEWSDPSDP LLVSVTGNSS SSSSSPTEPS SKTGIRRHLH
241 ILIGTSVAII LFIILFFFLL HCCCSNKKNA AVMDQEPAGD RTVNREDSDD QDPQEVTYAQ
301 LDHCVFTQTK ITSPSQRPKT PPTDTTMYME LPNAKPRSLS PAHKHHSQAL RGSSRETTAL
361 SQNRVASSHV PAAGILocalizationUniProt · AlphaFold · HPA
Whether an antibody against KIR2DL5A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.47
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KIR2DL5A as an antibody target. Whether an autoantibody or antibody against KIR2DL5A could matter depends on whether native KIR2DL5A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KIR2DL5A is annotated at the cell surface, where native KIR2DL5A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KIR2DL5A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...